Phosphodiesterase III inhibition or adrenoreceptor stimulation: Milrinone as an alternative to dobutamine in the treatment of severe heart failure

This publication has 27 references indexed in Scilit:

• The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: A 31P MRS study
  American Heart Journal, 1989
• Die Kombination von Dopamin und Dobutamin in der Differentialtherapie der akuten und chronischen Myokardinsuffizienz
  Deutsche Medizinische Wochenschrift (1946), 1985
• Drugs Five Years Later
  Annals of Internal Medicine, 1983
• The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
  American Heart Journal, 1983
• Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.
  Circulation, 1983
• Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure
  The American Journal of Cardiology, 1983
• Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse
  American Heart Journal, 1982
• Dobutamine in chronic ischemic heart failure: Alterations in left ventricular function and coronary hemodynamics
  The American Journal of Cardiology, 1981
• Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
  Circulation, 1981
• Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation
  Journal of Allergy and Clinical Immunology, 1977